• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶受体的过表达增加了人骨肉瘤细胞系的基质侵袭能力,而不改变细胞迁移能力。

Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.

作者信息

Karikó K, Kuo A, Boyd D, Okada S S, Cines D B, Barnathan E S

机构信息

Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104.

出版信息

Cancer Res. 1993 Jul 1;53(13):3109-17.

PMID:8391387
Abstract

Proteolysis triggered by receptor-bound urokinase-type plasminogen activator (uPA) involves a cascade of species-specific molecular interactions. To study the role of the uPA receptor (uPAR) in such interactions, a human osteosarcoma cell line (HOS), which normally expresses low levels of uPAR, was transfected with human uPAR complementary DNA. One of several stably transformed clonal cells lines, designated 2A2, was characterized and compared to the parental HOS, revealing the following: (a) stable incorporation of uPAR complementary DNA into the genome demonstrated by Southern blot analysis; (b) a 10-fold increase in steady state mRNA levels of uPAR assessed by Northern blot analysis; (c) a 2-fold increase in the surface expression of glycosylphosphatidylinositol anchored uPAR protein determined by enzyme-linked immunosorbent assay and by the specific binding of radiolabeled single chain uPA; (d) a 2-fold increase in internalization and degradation of radiolabeled uPA/PAI-1 complexes; and (e) a 2-fold increase in receptor-bound uPA-mediated plasmin generation measured by the cleavage of a chromogenic substrate and degradation of 125I-labeled laminin. The involvement of uPAR in cellular processes was determined by comparing 2A2 and HOS cells in in vitro migration and invasion assays. The migration of 2A2 cells were slower on fibronectin-coated surfaces in a linear under-agarose assay, but both cell lines migrated at the same rate on uncoated polycarbonate filters in Boyden chamber assays. In the invasion experiments, 4 times more 2A2 than HOS cells penetrated through the barrier of reconstituted basement membrane Matrigel. These data suggest that uPAR does not potentiate random cell migration but facilitates matrix degradation and subsequent cell invasion.

摘要

受体结合型尿激酶型纤溶酶原激活剂(uPA)引发的蛋白水解涉及一系列物种特异性分子相互作用。为了研究uPA受体(uPAR)在此类相互作用中的作用,将通常低水平表达uPAR的人骨肉瘤细胞系(HOS)用人类uPAR互补DNA进行转染。几个稳定转化的克隆细胞系之一,命名为2A2,进行了特性鉴定并与亲本HOS进行比较,结果如下:(a)通过Southern印迹分析证明uPAR互补DNA稳定整合到基因组中;(b)通过Northern印迹分析评估uPAR的稳态mRNA水平增加了10倍;(c)通过酶联免疫吸附测定法以及放射性标记的单链uPA的特异性结合确定,糖基磷脂酰肌醇锚定的uPAR蛋白的表面表达增加了2倍;(d)放射性标记的uPA/PAI-1复合物的内化和降解增加了2倍;(e)通过显色底物的裂解和125I标记的层粘连蛋白的降解测定,受体结合的uPA介导的纤溶酶生成增加了2倍。通过在体外迁移和侵袭试验中比较2A2和HOS细胞来确定uPAR在细胞过程中的参与情况。在直线型琼脂糖下试验中,2A2细胞在纤连蛋白包被的表面上迁移较慢,但在Boyden小室试验中,两种细胞系在未包被的聚碳酸酯滤膜上以相同速率迁移。在侵袭实验中,穿透重组基底膜基质胶屏障的2A2细胞比HOS细胞多4倍。这些数据表明,uPAR不会增强随机细胞迁移,但会促进基质降解和随后的细胞侵袭。

相似文献

1
Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.尿激酶受体的过表达增加了人骨肉瘤细胞系的基质侵袭能力,而不改变细胞迁移能力。
Cancer Res. 1993 Jul 1;53(13):3109-17.
2
Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells.抗尿激酶型纤溶酶原激活物受体脱氧核酶对骨肉瘤细胞尿激酶受体基因表达及细胞侵袭的抑制作用
FEBS J. 2005 Jul;272(14):3572-82. doi: 10.1111/j.1742-4658.2005.04778.x.
3
In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.反义尿激酶型纤溶酶原激活物受体对人胶质母细胞瘤细胞系侵袭性的体外抑制作用
Oncogene. 1997 Mar 20;14(11):1351-9. doi: 10.1038/sj.onc.1200963.
4
EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.表皮生长因子刺激的卵巢癌细胞迁移与尿激酶型纤溶酶原激活物受体的内化减少、表面表达增加和脱落增加有关。
Gynecol Oncol. 2006 Apr;101(1):28-39. doi: 10.1016/j.ygyno.2005.09.038. Epub 2005 Nov 2.
5
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.靶向人胰腺癌细胞中的尿激酶型纤溶酶原激活物受体可抑制c-Met和胰岛素样生长因子-I受体介导的迁移、侵袭以及小鼠原位肿瘤生长。
Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946.
6
Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.尿激酶型纤溶酶原激活物受体在血小板反应蛋白1介导的肿瘤细胞侵袭中的作用。
J Surg Res. 1999 Apr;82(2):331-8. doi: 10.1006/jsre.1998.5578.
7
Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.尿激酶与其受体的结合促进人黑色素瘤细胞在体外的迁移和侵袭。
Cancer Res. 1994 Jun 1;54(11):3066-71.
8
Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.反义组织蛋白酶B cDNA转染对人骨肉瘤细胞系侵袭和运动能力的抑制作用
Cancer Res. 1999 Dec 1;59(23):6010-4.
9
A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells.一种尿激酶受体mRNA结合蛋白与mRNA的相互作用调节人胸膜间皮瘤细胞中受体的表达和功能。
Arch Biochem Biophys. 1998 Aug 15;356(2):265-79. doi: 10.1006/abbi.1998.0789.
10
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.DU145人前列腺癌的侵袭性受表皮生长因子受体(EGFR)信号下游的尿激酶受体(uPAR)调节。
Exp Cell Res. 2004 Sep 10;299(1):91-100. doi: 10.1016/j.yexcr.2004.05.008.

引用本文的文献

1
Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025.上皮-间质转化(EMT)与癌症转移:2025年方法与实验模型的现状
Mol Cancer. 2025 Jun 7;24(1):167. doi: 10.1186/s12943-025-02338-2.
2
The Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer.非编码RNA对炎症和癌症中程序性细胞死亡4的调控作用
Front Oncol. 2019 Sep 18;9:919. doi: 10.3389/fonc.2019.00919. eCollection 2019.
3
The role of Pdcd4 in tumour suppression and protein translation.
Pdcd4在肿瘤抑制和蛋白质翻译中的作用。
Biol Cell. 2018 May 28. doi: 10.1111/boc.201800014.
4
Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1.通过上调 EGR1,尿激酶纤溶酶原激活物活性介导化疗抑制骨肉瘤细胞侵袭。
PLoS One. 2011 Jan 20;6(1):e16234. doi: 10.1371/journal.pone.0016234.
5
Challenges for drug discovery - a case study of urokinase receptor inhibition.药物研发面临的挑战——以尿激酶受体抑制为例的案例研究
Comb Chem High Throughput Screen. 2009 Dec;12(10):961-7. doi: 10.2174/138620709789824727.
6
Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.E-钙黏蛋白的下调是激活β-连环蛋白/Tcf 依赖性转录以及在 Pdcd4 敲低细胞中其靶基因表达的必要事件。
Oncogene. 2010 Jan 7;29(1):128-38. doi: 10.1038/onc.2009.302. Epub 2009 Sep 28.
7
The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?尿激酶受体(u-PAR)——肿瘤细胞休眠与骨髓微小残留病之间的联系?
APMIS. 2008 Jul-Aug;116(7-8):602-14. doi: 10.1111/j.1600-0463.2008.00997.x.
8
Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.Maspin调节缺氧介导的侵袭性乳腺癌细胞中尿激酶型纤溶酶原激活物/尿激酶型纤溶酶原激活物受体(uPA/uPAR)复合物的刺激作用。
Cancer Biol Ther. 2005 Apr;4(4):400-6. doi: 10.4161/cbt.4.4.1617. Epub 2005 Apr 21.
9
c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells.c-Met酪氨酸激酶受体在人及犬骨肉瘤细胞中的表达与功能
Clin Exp Metastasis. 2003;20(5):421-30. doi: 10.1023/a:1025404603315.
10
Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.尿激酶型纤溶酶原激活物受体表达的下调抑制了Erk信号传导,同时由于结肠癌细胞中uPAR-β1整合素复合物的缺失而抑制了侵袭性。
Br J Cancer. 2003 Jul 21;89(2):374-84. doi: 10.1038/sj.bjc.6601098.